The Association of the British Pharmaceutical Industry has been working on changes to the ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure.

The proposed changes follow work done by a group chaired by Hugo Fry, Sanofi UK Country Chair and General Manager Sanofi Pasteur, established by the ABPI Board, as well as feedback from member companies, patient organisations and others.

The requirements of the ABPI Code of Practice and its administration by the PMCPA demonstrate the commitment of the pharmaceutical industry to benefiting patients by operating in a professional, ethical and transparent manner.  Regular updates are vital to ensure that self-regulation in the pharmaceutical industry maintains its relevance and strength. 

The details are set out on the PMCPA website and your comments would be appreciated as part of our consultation.

Comments are closed.